Back
ESC2025 Premium Access

The SLCO1B1 c.521 T > C variant is not associated with muscular symptoms or PCSK9-inhibitor prescription in patients with severe hypercholesterolemia

Session: Lipids (1)
Topic: Lipids
Speaker: Doctor L. Galli (Vienna, AT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Lukas Galli

Medical University of Vienna, Vienna (Austria)
0 follower

4 more presentations in this session

Predictive value of blood count derived inflammatory markers for LDL cholesterol target achievement after STEMI

Speaker: Doctor V. Halatiu (Targu Mures, RO)

Access
Abstract
Slides
Video
Like
Thumbnail

Treatment quality in patients with familial hypercholesterolemia in Denmark

Speaker: Doctor J. Knold (Odense, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Suboptimal LDL-C control despite high statin use: insights from the LAI-LCARE survey on secondary CAD prevention in India

Speaker: Doctor K. Mahajan (Himachal Pradesh, IN)

Access
Abstract
Slides
Video
Like
Thumbnail

Early post-discharge follow-up improves lipid control and reduces cardiovascular risk in ACS patients: insights from a tertiary cardiac centre

Speaker: Doctor A. Elkammash (Bristol, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Lipids (1)

Speakers: Doctor L. Galli, Doctor V. Halatiu, Doctor J. Knold, Doctor K. Mahajan, Doctor A. Elkammash
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources